Login to Your Account



Financings Roundup

Agennix Brings in $13M to Keep Phase III Cancer Trials Moving

By Catherine Hollingsworth


Tuesday, March 23, 2010
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription